Harm Reduction

Supervised Injection Services in Toronto

Tel: 416-392-0520

277 Victoria Street (Yonge & Dundas)

Site hours: Monday - Saturday, 4 - 10 p.m. 

Frequently Asked Questions:

What is a supervised injection service?

Toronto Public Health, Queen West-Central Community Health Centre and South Riverdale Community Health Centre are planning to add small-scale supervised injection services to their existing clinical health services for people who inject drugs. This is a different model than Vancouver's InSite. Supervised injection services are health services that provide a hygienic environment for people to inject pre-obtained drugs under the supervision of a nurse. In addition to supervised injection, individuals are provided with sterile injection supplies, education on safer injection, overdose prevention and intervention, medical and counselling services, and referrals to drug treatment, housing, income support and other services.     

How will these services work?

The majority of people using these services will be existing clients. Clients will arrive at the program with pre-obtained drugs. Each person will be assessed to ensure they are eligible for the program. They will be given sterile injecting equipment and instruction on safer injecting practices. A nurse will then supervise their injection in a room dedicated for this purpose, and intervene in the case of any medical emergencies. Once the individual has injected their drugs they will be directed to a waiting room where they will continue to be observed for any negative drug reactions. They will also receive information and referrals about other health and social supports and services at the agency or elsewhere in the community.

Are supervised injection services legal?

Yes. In Canada, legal operation of a supervised injection service requires an exemption under Section 56 of the Controlled Drugs and Substances Act (CDSA). Exemptions are granted by the federal Minister of Health. In 2015, the federal government passed the Respect for Communities Act, which outlines the process and criteria for applicants seeking a Section 56 exemption. 

Are there supervised injection services in other cities?

The first supervised injection service opened 30 years ago in Switzerland. Today there are more than 90 supervised injection services worldwide, including in Europe, Australia and Canada. In Canada, there are two supervised injection services in Vancouver. Several supervised injection services are also being planned for Montreal. 

What are the benefits of these services?

International and Canadian research shows that supervised injections services have benefits both for individuals using the services and for the community, including:

  • Reducing the number of drug overdoses and deaths
  • Reducing risk factors leading to infectious diseases such as HIV and hepatitis
  • Increasing the use of detox and drug treatment services
  • Connecting people with other health and social services
  • Reducing the amount of publicly discarded needles
  • Cost-effectiveness
  • Not contributing to crime or increased drug use in the local community

Where will these services be located?

Three agencies are planning to add supervised injection to their existing health services for people who inject drugs. The agencies are Toronto Public Health (The Works), Queen West-Central Toronto Community Health Centre, and South Riverdale Community Health Centre. 

What is being proposed for Toronto?

The proposal for Toronto is to add small-scale supervised injection services to existing health services for people who inject drugs. This is a different model than Vancouver's InSite. The services in Toronto would be located within the agency's existing program space with no change to the exterior of the building. Three supervised injection services are proposed because drug use is spread out rather than concentrated in Toronto. Research finds people will only travel a short distance to use a supervised injection service.

  Photo: Example of small scale supervised injection service at the Dr. Peter Centre, Vancouver.

Photo: Example of small scale supervised injection service at the Dr. Peter Centre, Vancouver.   

Why do we need supervised injection services in Toronto?

Research has concluded that Toronto would benefit from multiple supervised injection services that are integrated into health services already working with people who inject drugs.

Conditions in Toronto support the need for supervised injection services. There is a high demand for harm reduction services. In 2015, there were over 100,000 client visits to harm reduction services, and almost 1.9 million needles were distributed along with other sterile injection supplies through community agencies across the city. Overdoses in Toronto are on the rise. In 2013, there were 206 people died from drug overdoses in Toronto, the highest annual number to date. This represents a 41% increase from 2004. Of particular concern is the increasing role of opioids, such as heroin and fentanyl, in these deaths. Rates of HIV (5%) and hepatitis C (61%) infection among people who inject drugs are much higher than for the general population. In addition, a Toronto study found 36% of people who use drugs reported injecting in public places such as washrooms and alleyways.

Why is supervised injection needed at these locations?

The three agencies planning to provide supervised injection services already deliver harm reduction services to a significant number of people who inject drugs, including people who are engaging in high-risk behaviours such as injecting alone, frequently, and in public. Each agency has delivered harm reduction services in their community for over 20 years. They have multi-disciplinary health teams providing health care and support to people who use drugs.


These agencies are three of the busiest needle distribution programs in Toronto. Together they distribute almost 75% of all sterile needles in the city:

  • The Works at Toronto Public Health had almost 14,000 client visits with over 800,000 needles distributed in 2015.
  • Queen West- Central Toronto Community Health Centre had over 15,000 client visits with almost 300,000 needles distributed in 2015.
  • South Riverdale Community Health Centre had over 22,000 client visits with over 320,000 needles distributed. 

Will the supervised injection services increase crime in our neighbourhood?

Supervised injection services do not contribute to more crime. They are located in neighbourhoods where there is a demonstrated need, usually where drug use is already having an impact on the community. There is considerable research on this subject. For example, in the neighbourhood around InSite in Vancouver, there has been no increase in crime, and actual decreases in vehicle break-ins and thefts. Australian studies have found decreases in drug-related crime, public drug use and loitering.

Won't these services just encourage more drug use?

People do not start injecting drugs because of the availability of supervised injection services. There is no evidence that harm reduction services promote drug use. Supervised injection services are used mainly by people with a long history of injection drug use. Research has also found that supervised injection services do not cause people to relapse (e.g., start using drugs after a period of abstinence) or prevent people from stopping drug use altogether.

What else is being done to address drug issues in Toronto?

Many organizations across the city deliver a broad range of services to reduce the harms of substance use. This includes prevention programs as well as withdrawal management and treatment programs. Toronto also has a City Council-approved strategy that provides a comprehensive approach to alcohol and other drugs based on the four integrated components of prevention, harm reduction, treatment, and enforcement. Action is being taken across each of these areas. Implementation of supervised injection services will not eliminate harmful drug use, but they are part of the range of strategies to reduce harm. Details about the implementation of the Toronto Drug Strategy are provided every two years in a status report.

Back to: Harm Reduction